RSHO and RSHO-X Garner Global Headlines as Part of Cannabis World Congress and Business Expo in New York
SAN DIEGO, CA–(Marketwired – June 21, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) is pleased to announce today that its hemp oil products and CEO Dr. Stuart Titus were featured in global news coverage including TV interviews and news articles as part of coverage from the Cannabis World Congress and Business Expo (CWCBE), which was held at the Javits Center in New York City from June 16-17. Dr. Titus spoke at the CWCBE about how the world stands to benefit both nutritionally and therapeutically from the company’s Cannabidiol (CBD) products, including Real Scientific Hemp Oil™ (RSHO™) and Real Scientific Hemp Oil-X™ (RSHO-X™).
“We were the first publicly traded company in the medical marijuana and industrial hemp space in the United States,” FOX 5 News quoted Titus as saying. “Based on Colorado’s numbers, if marijuana was legalized throughout the U.S., we’d have a $120 billion business just based on recreational.”
ABC News also featured a lengthy report on Medical Marijuana, Inc. receiving the historic, first-ever import permits for cannabis products from federal health officials in Brazil, Mexico and Paraguay and photos from Getty Images also featured the Company’s HempVĀP® and RSHO-X™.
“We’re impressed and humbled that respected members of the news media in New York are telling our Company’s story and covering the newest multibillion-dollar U.S. industry,” said Dr. Titus. “It’s an exciting time to be involved in the cannabis industry, and it’s our goal at conferences like these to educate audiences on the plethora of benefits that our products can bring to people around the world. The Company and our world-class team will continue to be pioneers and leaders blazing the trail for other successful entrepreneurs in the industry to follow.”
On June 9, 2016, Ohio became the 25th U.S. state to allow qualified patients access to medical cannabis for medicinal use, citing 21 qualifying medical indications (and if one includes Louisiana’s limited law, this figure would be 26 states). Including U.S. territories Puerto Rico and Guam, as well as the District of Columbia, Ohio’s milestone achievement translates to more than 50% of the U.S. with full-spectrum medical cannabis laws enacted. In addition, there are 16 U.S. states with limited medical cannabis access laws enacted, which brings the total of all U.S. states, districts or territories with some form of cannabis law to 43.
Following are articles based on the events and news surrounding Medical Marijuana, Inc.’s presence at this week’s CWCBE, with more to come:
Fox 5 New York: http://www.fox5ny.com/news/160812124-story
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
P. 888-829- 0070
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500